|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/46 | |
| A61P 3/00 |
| (11) | Patento numeris | 2793933 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12860231.5 |
| Europos patento paraiškos padavimo data | 2012-12-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/071495 |
| Data | 2012-12-21 |
| (87) | Numeris | WO 2013/096912 |
| Data | 2013-06-27 |
| (30) | Numeris | Data | Šalis |
| 201161580027 P | 2011-12-23 | US | |
| 201261590797 P | 2012-01-25 | US | |
| 201261590804 P | 2012-01-25 | US | |
| 201261609173 P | 2012-03-09 | US | |
| 201261734365 P | 2012-12-06 | US |
| (72) |
BARBIER, Ann, US
MCCAULEY, Thomas, US
RICHARD, Charles, W., III, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
| (54) | TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2-SULFATASE |
| TREATMENT OF COGNITIVE IMPAIRMENT OF HUNTER SYNDROME BY INTRATHECAL DELIVERY OF IDURONATE-2-SULFATASE |